About 8,480,000 results
Gilead taps Korea's Yuhan to supply HIV drug ingredients in $81M …
Yuhan inks $80.9M deal with Gilead Sciences for HIV drug …
Yuhan, Janssen halt next-gen cancer drug collaboration - The …
Yuhan inks $81 mn contract with U.S. Gilead to supply HIV …
Yuhan set to receive $60 m from Janssen for ... - 조선일보
Yuhan Shares Jump 4% After US FDA Approves Anti-Cancer Drug …
Yuhan eyes next Leclaza with R&D, open innovation after U.S.
Yuhan nabs Ubix cancer drug for ₩150B; YH-35995 trial cleared
Yuhan Corporation and J INTS BIO inked a licensing agreement …
Yuhan to pay ₩208B for Cyrus-Kanaph’s SOS1 inhibitor for cancer